HRMY - Harmony Biosciences Holdings Inc
28.79
0.050 0.174%
Share volume: 544,083
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$28.74
0.05
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-30-2024 | 08-06-2024 | 10-29-2024 | 02-25-2025 | 05-06-2025 | 11-04-2025 | 02-24-2026 | |
| Assets | ||||||||
| Total Assets | 846.985 M | 858.383 M | 928.135 M | 999.200 M | 1.056 B | 1.208 B | 1.272 B | |
| Current Assets | 479.503 M | 458.344 M | 522.405 M | 579.252 M | 642.692 M | 838.800 M | 907.014 M | |
| Inventories | 5.857 M | 5.643 M | 6.915 M | 7.198 M | 6.384 M | 6.882 M | 5.357 M | |
| Other Current Assets | 8.683 M | 6.507 M | 7.455 M | 8.121 M | 6.916 M | 35.378 M | 13.516 M | |
| Short Term Investments | 39.369 M | 29.614 M | 23.109 M | 14.185 M | 17.955 M | 25.582 M | 22.838 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 332.981 M | 317.296 M | 387.367 M | 453.001 M | 488.998 M | 646.999 M | 752.502 M | |
| Total Non-current Assets | 81.244 M | 87.178 M | 94.222 M | 108.874 M | 103.245 M | 105.831 M | 107.127 M | |
| Property Plant Equipment | 213.000 K | 754.000 K | 750.000 K | 1.257 M | 1.378 M | 1.440 M | 0.000 | |
| Other Assets | 367.269 M | 399.285 M | 404.980 M | 418.691 M | 411.465 M | 367.978 M | 364.617 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 846.985 M | 858.383 M | 928.135 M | 999.200 M | 1.056 B | 1.208 B | 1.272 B | |
| Total liabilities | 331.591 M | 319.800 M | 331.331 M | 340.045 M | 335.010 M | 373.095 M | 401.413 M | |
| Total current liabilities | 154.253 M | 146.582 M | 161.279 M | 175.082 M | 175.118 M | 223.403 M | 252.132 M | |
| Accounts Payable | 15.144 M | 22.683 M | 10.532 M | 13.744 M | 17.459 M | 26.341 M | 17.693 M | |
| Other liabilities | 2.342 M | 1.796 M | 2.205 M | 1.947 M | 1.710 M | 1.186 M | 5.618 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 174.996 M | 171.422 M | 167.847 M | 163.016 M | 158.182 M | 148.506 M | 143.663 M | |
| Other liabilities | 2.342 M | 1.796 M | 2.205 M | 1.947 M | 1.710 M | 1.186 M | 5.618 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 515.394 M | 538.583 M | 596.804 M | 659.155 M | 720.525 M | 835.123 M | 870.218 M | |
| Common stock | 620.508 M | 632.169 M | 643.564 M | 656.873 M | 672.504 M | 696.349 M | 708.969 M | |
| Retained earnings | -104.943 M | -93.352 M | -47.259 M | 2.216 M | 47.776 M | 138.417 M | 160.903 M |